SLC11A1 and pulmonary tuberculosis: Pronounced tenfold differences between populations were furthermore observed for the missense variant rs17235409 in SLC11A1 that is implicated in treatment failure of patients with pulmonary tuberculosis to isoniazid, rifampicin, pyrazinamide, and ethambutol combination therapy (Salinas-Delgado et al. 2015).